DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Isoniazid
Isoniazid
General Items
Informatorium of COVID-19 Drugs in Indonesia" Has Been Compiled and Can Be Published Amidst the COVID-19 Outbreak in Indonesia
Clinical Pharmacology and Biopharmaceutics Review(S)
WHO Report on Surveillance of Antibiotic Consumption: 2016-2018 Early Implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some Rights Reserved
Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides
Treatment of Drug-Resistant Tuberculosis an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R
Marrakesh Agreement Establishing the World Trade Organization
Publications 2016 – 2018
Customs Tariff - Schedule
Frequently Asked Questions on The
Swedres Svarm 2012
Anti-Infective Drug Poster
Antibacterial Prodrugs to Overcome Bacterial Resistance
Tuberculosis Drug Information Guide, 2Nd Edition
298 Antibacterials
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
Review of Existing Classification Efforts
Chemical Disarming of Isoniazid Resistance in Mycobacterium Tuberculosis
Top View
ISONIAZID (INH): Chemical Structure
Tuberculosis Re-Treatment After Exclusion of Rifampicin Resistance
Recommendation the 23Rd SEC (Antimicrobial & Anti-Viral)
2004 Norm Norm-Vet
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
6-Veterinary-Medicinal-Products-Criteria-Designation-Antimicrobials-Be-Reserved-Treatment
Isoniazid (Inh) Fact Sheet
The Decrease in Antibiotic Funding
TB Drug Adverse Reactions
GLASS Methodology for Surveillance of National Antimicrobial Consumption
Antibacterial Activity of Salicylanilide 4-(Trifluoromethyl) Benzoates
TASK for SUBMODULE CONTROL № 6 List of Drugs
Migration of Gas Bubbles Among the Subarachnoid Space, the Subretinal
Polymyxin Delivery Systems: Recent Advances and Challenges
WHO Consolidated Guidelines on Tuberculosis WHO Operational
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
An Integrative, Multi-Omics Approach Towards the Prioritization Of
Activity of Lipophilic and Hydrophilic Drugs Against Dormant and Replicating Mycobacterium Tuberculosis